Some of Sanofi’s most high-profile readouts this year can’t have made for easy reading at the French pharma’s Paris ...

On the FDA’s docket for the back half of September is Merck’s proposed subcutaneous formulation of its blockbuster cancer ...

Sanofi to present new data from 14 abstracts across multiple sclerosis at ECTRIMS 2025 congress in Barcelona, Spain ...

Specialty and orphan drugs continue to dominate the development pipeline, and a new report from Optum Rx spotlights three products payers should be watching. | Specialty and orphan drugs continue to ...

While Sanofi originally had its eye on tolebrutinib when it purchased its partner Principia Biopharma for $3.7 billion five years ago, another one of the Bruton tyrosine kinase (BTK) inhibitors ...

The United Arab Emirates became the first country to approve tolebrutinib, clearing it to treat adults with nonrelapsing secondary progressive multiple sclerosis (SPMS). Sanofi’s oral BTK inhibitor is ...

ABU DHABI, 28 August (BelTA - Emirates News Agency) - In a landmark regulatory achievement that reflects the UAE’s leadership in accelerating access to innovative therapies, the Emirates Drug ...

Cairo [Egypt], August 27 (ANI/WAM): The Arab Parliament has strongly condemned the dangerous escalation in the West Bank. The latest actions include the brutal incursions by Israeli occupation forces ...

In a landmark regulatory achievement that reflects the UAE’s leadership in accelerating access to innovative therapies, the Emirates Drug Establishment has announced the approval of “Tolebrutinib” as ...

Lucknow: Chief Minister Yogi Adityanath has directed officials to implement the Uttar Pradesh Electronics Component Manufacturing Policy-2025 to establish the state as a global electronics ...

Mysuru: Senior JD(S) leader and Chamundeshwari MLA GT Devegowda on Tuesday defended the decision to invite International Booker Prize winner Banu Mushtaq to inaugurate this year's Dasara festival, ...